Offerings - Offering: 1 |
Aug. 20, 2025
USD ($)
|
|---|---|
| Offering: | |
| Fee Previously Paid | false |
| Rule 457(r) | true |
| Security Type | Equity |
| Security Class Title | Common stock, par value $0.000041666 per share |
| Maximum Aggregate Offering Price | $ 350,000,000.00 |
| Fee Rate | 0.01531% |
| Amount of Registration Fee | $ 53,585.00 |
| Offering Note | (1) Consists of shares to be issued pursuant to that certain Amended and Restated Open Market Sales AgreementSM, or the Sales Agreement, dated August 22, 2025, between Iovance Biotherapeutics, Inc. and Jefferies LLC. (2) Calculated in accordance with Rule 457(o) and Rule 457(r) under the Securities Act of 1933, as amended. Represents payment of registration fees previously deferred in connection with the Registration Statement on Form S-3ASR (Registration No. 333-272718). |